[Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)]
- PMID: 28403966
- DOI: 10.1016/j.jogoh.2016.09.001
[Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)]
Abstract
Objectives: The aim of our study was to evaluate in utero blood transfusion's (IUT) performed in France, among the French prenatal diagnosis centers in order to study the etiology of severe anemia requiring IUT.
Methods: We conducted a national retrospective descriptive study between 2011 and 2014. The data were collected using a survey sent by email to all French prenatal diagnosis centers.
Results: Among the 49 centers, 18 (38 %) had performed at least one IUT during the study period. The geographical repartition of these centers was appropriate for the "Aquitaine Pyrénées" region. Five centers performed 68 % of the national activity and one center performed 40 % the national activity. Each year, a mean of 204 IUTs were performed in 113 pregnancies. The principal etiology of severe fetal anemia requiring IUT was hemolytic disease of the fetus (69 % of the etiologies) with anti-RhD being the most prevalent antibody. The second etiology was represented by parvovirus B19 infection (17 % of IUTs).
Conclusion: The French IUT activity was stable in numbers and indications during the study period. A national register could be set up in order to better evaluate prospectively the number of pregnancies concerned by IUT and to study the prevalence of hemolytic disease of the fetus due to anti-RhD antibodies.
Keywords: Allo-immunisations érythrocytaires; Anémie fœtale; Complicated pregnancies; Complications de la grossesse; Fetal anemia; Fetal red cell transfusion; Incompatibilité fœto-maternelle érythrocytaire; Infection à parvovirus; Maladie rhésus; Maternal alloimmunization; Materno-fetal red blood cell incompatibility; Parvovirus B19 infection; Transfusion in utero.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Neonatal outcome after fetal anemia managed by intrauterine transfusion.Eur J Pediatr. 2015 Nov;174(11):1535-9. doi: 10.1007/s00431-015-2573-x. Epub 2015 Jun 2. Eur J Pediatr. 2015. PMID: 26032762
-
[Follow-up of pregnancies with red-cell allo-immunisation: State-of-the art].Gynecol Obstet Fertil. 2010 Mar;38(3):205-13. doi: 10.1016/j.gyobfe.2010.01.012. Epub 2010 Mar 6. Gynecol Obstet Fertil. 2010. PMID: 20207183 French.
-
Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.Br J Haematol. 2022 Feb;196(4):1096-1104. doi: 10.1111/bjh.17956. Epub 2021 Dec 4. Br J Haematol. 2022. PMID: 34862601
-
Management of red blood cell alloimmunization in pregnancy.J Gynecol Obstet Hum Reprod. 2018 May;47(5):197-204. doi: 10.1016/j.jogoh.2018.02.001. Epub 2018 Feb 21. J Gynecol Obstet Hum Reprod. 2018. PMID: 29476829 Review.
-
[Management of feto-maternal red cell allo-immunizations].Transfus Clin Biol. 2011 Apr;18(2):269-76. doi: 10.1016/j.tracli.2011.01.005. Epub 2011 Mar 11. Transfus Clin Biol. 2011. PMID: 21397546 Review. French.
Cited by
-
Hemolytic disease of the fetus and newborn-a perspective of immunohematology.Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S246-S257. doi: 10.1016/j.htct.2024.04.122. Epub 2024 Aug 18. Hematol Transfus Cell Ther. 2024. PMID: 39242288 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical